Shock as four KZN health workers die in one week — two while on duty
The PSA said it had previously flagged concerns about ill-treatment of staff and autocratic leadership at the hospital with the health department.
'To date, no meaningful investigation or intervention has been conducted. This is not an isolated case. Many doctors and health-care workers in KwaZulu-Natal continue to suffer under hostile, exploitive and toxic management, often working under impossible conditions without support.'
Dhlomo said Penny Msimango, the acting head of the provincial health department, has committed to investigate the circumstances around Mazwi's death.
He said it was heartbreaking that someone who dedicated his life to serving others had 'encountered a situation that should have been managed with the utmost urgency and care. It is a reminder of the challenges faced by medical professionals, especially those just beginning their careers. Their commitment to healing and care should never be compromised by preventable circumstances.
'We must reflect on the urgent need for reform in our health-care system. We cannot afford to lose more young lives to preventable incidents. It is crucial that we work together to ensure medical interns and professionals are provided with the necessary support, resources and environment to thrive.'
Health MEC Nomagugu Simelane said the department is struggling to come to terms with the loss of four staff members this week: Dr Siyabonga Zulu, a medical officer in the department of anaesthesia at Ngwelezane Hospital, died in a road accident on Sunday.
Mazwi and Mvelo Cele, a radiographer at Port Shepstone Hospital, died at work over the next two days.
The department was dealt another blow when Dr Tumelo Kgaladi, who worked at Addington Hospital's obstetrics and gynaecology unit, died at his home in Clare Estate.
'These consecutive losses have left a huge void. Each of them represented a future filled with promise, professional excellence and the ability to inspire and uplift those around them,' said Simelane.
This is a developing story
TimesLIVE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Herald
2 hours ago
- The Herald
Cape Town lab tests thousands of samples as city notes increase in foodborne illnesses
Noting a gradual increase in foodborne illnesses, the City of Cape Town says its microbiological laboratory has tested nearly 5,000 food samples over 10 months to verify the items were safe to eat. Tests are conducted on ready-to-eat and dairy products, from sushi to baked goods. The laboratory also conducts testing of samples in cases of foodborne illnesses. Food handling, production and processing environments from manufacturers to retailers and takeaways to old age homes, informal traders and spaza shops are included in the sampling. 'The testing is essential for identifying unhygienic conditions, poor food handling practices and possible contamination to prevent potential outbreaks,' said the city. 'Over 10 months since July 2024, the laboratory received 4,853 samples that were subjected to 17,759 analyses. The sample results yielded an overall compliance rate of 84.55%.' The city said it had noted a 'steady increase' in reported foodborne illnesses from July 2022 to April 2025. 'As Covid-19 restrictions eased, there was a return to normal food handling, dining and social behaviours. This may have led to increased exposure to foodborne pathogens and a rebound in reported cases. The increase in notifications, specially in 2024, may also reflect better detection, reporting and surveillance systems as public health operations normalised post-pandemic,' said community services and health MMC Francine Higham. 'However, as the underreporting of foodborne illness is known to be extensive, the actual incidence is likely to be far higher, which reinforces the need for regular testing of foodstuffs in the public domain.' The city described its health department's food microbiological laboratory and environmental health practitioners as frontline defenders against foodborne illnesses. TimesLIVE
Mail & Guardian
3 hours ago
- Mail & Guardian
Monthly prescription rule blocks ADHD treatment for South African children
Attention deficit and hyperactivity disorder affects 5% to 7% of schoolgoing children, but doctors can only prescribe treatment for a month at a time Attention deficit and hyperactivity disorder (ADHD) Methylphenidate, a Studies have shown that when the methylphenidate — the Methylphenidate is, however, classified as a This means patients need to visit their doctor each month for a new prescription, so in the private sector they'd need to pay for a doctor's visit each month, on top of paying for the medication, and in the public sector patients would need to take a day each month to queue up at their local clinic — and they'd have to make sure it's a day on which a doctor, as opposed to only nurses, are available at their health facility. The current scheduling creates huge administrative and financial difficulties for patients and caregivers when they try to get treated, especially for those navigating ADHD's very symptoms: executive dysfunction, forgetfulness and inattention. As a psychiatrist, working in both the public and private healthcare sector, I've seen the toll that untreated ADHD takes on children, adults and families — from fractured educational journeys to unemployment, depression, addiction and even suicide. These are not theoretical risks but daily realities for many South Africans. And yet one of the biggest obstacles that locks people out of treatment — our own healthcare policies — remains unchanged. It's time that we change that script. Our medicines regulator, the Here are four reasons why methylphenidate should be a schedule five medication. More people with ADHD will get treated ADHD is not rare — a In While we rightly invest in treating chronic conditions such as diabetes and hypertension, we continue to overlook the profound, lifelong effect of untreated ADHD. These factors contribute to the burden of disease and consequent stress on the health system — but most importantly, they reduce the quality of life of people with ADHD and their families. Medication can change this, yet access is limited. In many poorer communities Although stigma and the cost of methylphenidate ( Current scheduling does not prevent abuse Opponents of rescheduling often cite concerns about misuse — especially among tertiary students using methylphenidate for academic enhancement. Although these concerns are valid, evidence suggests that the current schedule six classification does little to prevent non-medical use. Studies show that Meanwhile, genuine patients — particularly children and teenagers — are penalised by overly restrictive policies that reduce access to the very medicine designed to help them succeed. We must ask ourselves: is the current scheduling preventing abuse, or is it merely restricting access for those who need it most? If the answer is the latter, then we have an ethical obligation to change course. Rescheduling does not mean deregulation. It means creating a more nuanced, risk-based framework — one that acknowledges both the need for control and the realities of living with a chronic disorder. More people will take their medicine correctly How well someone adheres to their medication, determines, to a large extent, how well the medicine works for them. But studies show For people with ADHD — with symptoms that impair their ability to organise, plan and follow through — the monthly schedule six script requirement can become a self-defeating cycle. The very condition we are trying to treat creates challenges in adhering to its treatment. Unsurprisingly, participants in the Moreover, research shows, people with ADHD who use their medication correctly, are also more likely to adhere to medication for other conditions, for The state is doing the same thing for antidepressants and anti-anxiety meds ADHD medication is not the only psychiatric medicine that needs rescheduling. South Africa's But the government health system — which most HIV-positive people in the country use to get their treatment — doesn't have nearly enough doctors to staff clinics full-time. Instead, nurses run such clinics, with doctors only doing shifts once or twice a week. Getting nurses to diagnose mental health conditions and to prescribe treatment, will mean that patients won't have to return for doctors' appointments to get treated. Policy is never value neutral. It reflects what we, as a society, choose to prioritise. In the case of ADHD, we must choose inclusion over exclusion, access over fear, and healing over harm. Rescheduling methylphenidate is not about giving up control; it's about restoring agency to patients, families and clinicians alike. response from chief executive Boitumelo Semete-Makokotlela : Sahpra is open to the rescheduling of scheduled substances. For this to happen, either the manufacturer of a medicine or anyone in the scientific community who has data for us to consider has to submit a request for rescheduling, along with the required scientific and clinical data. We'll have our names and scheduling committee, as well as our clinical committee, review the submissions. We would also consider additional data, outside of what would have been provided, and then make a decision. This process takes about 120 days. Professor Renata Schoeman is a Cape Town-based psychiatrist and the co-author of South Africa's and chairs the special interest group for ADHD. She serves on the ministerial advisory committee for mental health and heads up the healthcare leadership MBA specialisation stream at Stellenbosch University. This story was produced by the . Sign up for the .
IOL News
5 hours ago
- IOL News
Unlocking Africa's data potential: the launch of the African Bioinformatics Institute
Univeristy of Cape Town. Image: File In an epoch-defining milestone for scientific collaboration and capacity building across Africa, the African Bioinformatics Institute (ABI) has officially launched, inheriting interim hosting support from the University of Cape Town's (UCT) esteemed Institute of Infectious Disease and Molecular Medicine (IDM). This transformative initiative is poised to propel the continent into a data-powered future, driving forward bioinformatics research and infrastructure with the goal of unleashing Africa's vast potential in health, development, and innovation. The launch of the ABI followed a landmark gathering featuring over 200 scientists, policymakers, and institutional leaders hailing from across Africa and beyond. All present shared an unwavering commitment to cultivating an integrated, Africa-led ecosystem devoted to data-driven discoveries, a vital venture for the continent's future. Currently hosted by UCT's IDM, the ABI capitalises on a robust institutional foundation and a rich legacy of leadership in genomics, health, and bioinformatics research. Within the next months, ABI will establish itself as a non-profit organisation (NPO), which will solidify its long-term independence and reinforce its commitment to an Africa-led agenda. The ABI's formation signifies a substantial leap forward for empowering African researchers to lead the charge in bioinformatics and data science. Interim lead of the ABI and head of the Computational Biology Division at UCT, Professor Nicky Mulder expressed optimism about the institute's potential: 'The launch of the ABI marks a major milestone towards building a genuinely Africa-led research ecosystem.' 'Bioinformatics and data science are the cornerstones of research that will help us achieve the UN Sustainable Development Goals. The ABI is well-positioned to play a foundational role in investing in world-class training, infrastructure, and collaboration, which will drive Africa's scientific growth in the coming years,' she said. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ With seed funding from the Wellcome Trust and the Chan Zuckerberg Initiative, the ABI aims to serve as a catalyst for cutting-edge genomics research and health advancements. The anticipated development of African infrastructure will empower local researchers to analyse pathogens, monitor diseases, and implement evidence-based policy, paving the way for sustained health improvements across the continent. Ekin Bolukbasi, Technology Manager for Data for Science and Health at Wellcome, said there is a growing demand for bioinformatics. 'Given the rapid pace of technological advancement, bioinformatics and data science have become essential for research-driven decision-making. The ABI has an ambitious vision to establish itself as a continent-wide skills and infrastructure hub, enabling the use of biological data to enhance the lives of African citizens.' In recent years, Africa has witnessed a surge in biological and environmental data generation, primarily propelled by advancements in genomics and public health surveillance. However, the infrastructure and expertise required to effectively manage and interpret this influx of data has remained erratic. The ABI aims to bridge this gap through enhanced training, establishing interoperable systems, and championing local leadership in data science. Dario Taraborelli, science program officer at the Chan Zuckerberg Initiative, said Africa's leaders in genomics, biodiversity research, and disease surveillance have been operating without the unified data infrastructure they rightly deserve. We are proud to support the African Bioinformatics Institute as it lays the groundwork for the data and bioinformatics backbone needed across the continent, addressing the priorities of its scientific community and unlocking breakthrough discoveries that will benefit its distinct and diverse populations.' The African Bioinformatics Institute is focused on aligning its goals with the United Nations Sustainable Development Goals and the African Union's Agenda 2063 by: Enhancing the continent's capacity in bioinformatics through training, infrastructure, and collaborative networks. Establishing infrastructure that enables African researchers to analyse, interpret, and integrate complex datasets essential for tackling local and continental challenges. Supporting pandemic preparedness by providing access to high-quality, interoperable bioinformatics tools and platforms. Facilitating the implementation of One Health by linking human, animal, and ecosystem health to strengthen the response to emerging health threats. Since its inception in January 2025, the ABI has established an interim governance council and is actively identifying regional nodes to ensure comprehensive geographical representation and research diversity. Its interim hosting at UCT's IDM - a globally recognised leader in health research - highlights UCT's pivotal role as a continental epicentre for scientific excellence. Recently, in April 2025, the ABI endorsed the ISCB-Africa ASBCB Bioinformatics Conference in Cape Town, which convened students and early-career researchers alongside established scientists to foster collaboration and information exchange. The institute's momentum is set to continue as it prepares to launch its inaugural training programme and cultivate communities of practice across various thematic research areas.
